Endocrine immune-related adverse events: a double-edged sword?

por Rengarajan, Michelle, Gainor, Justin F.
Publicado 2021

Letter to the Editor Reply: Kleebayoon et al.

por Meador, Catherine B., Gainor, Justin F.
Publicado 2023

ALK Fusion Detection in Circulating Free DNA: Finding an Important Needle in the Haystack

por Mooradian, Meghan J., Gainor, Justin F.
Publicado 2017

Survival in a case of diffuse alveolar hemorrhage due to Strongyloides stercoralis hyperinfection

por Steinhaus, Daniel A., Gainor, Justin F., Vernovsky, Inna, Winsett, Julie, Beer, Dennis J.
Publicado 2012

Spirometry at diagnosis and overall survival in non‐small cell lung cancer patients

por Zhai, Ting, Li, Yi, Brown, Robert, Lanuti, Michael, Gainor, Justin F., Christiani, David C.
Publicado 2022

Hospice use and end‐of‐life care among older patients with esophageal cancer

por Tramontano, Angela C., Nipp, Ryan, Kong, Chung Yin, Yerramilli, Divya, Gainor, Justin F., Hur, Chin
Publicado 2018

A Phase II Study of the Multikinase Inhibitor Ponatinib in Patients With Advanced, RET-Rearranged NSCLC

por Gainor, Justin F., Gadgeel, Shirish, Ou, Sai-Hong I., Yeap, Beow, Otterson, Gregory A., Shaw, Alice T.
Publicado 2020

Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States

por Criss, Steven D., Mooradian, Meghan J., Watson, Tina R., Gainor, Justin F., Reynolds, Kerry L., Kong, Chung Yin
Publicado 2019

Imaging Features and Patterns of Metastasis in Non-Small Cell Lung Cancer with RET Rearrangements

por Digumarthy, Subba R., Mendoza, Dexter P., Lin, Jessica J., Rooney, Marguerite, Do, Andrew, Chin, Emily, Yeap, Beow Y., Shaw, Alice T., Gainor, Justin F.
Publicado 2020

Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer

por Bauer, Todd M., Shaw, Alice T., Johnson, Melissa L., Navarro, Alejandro, Gainor, Justin F., Thurm, Holger, Pithavala, Yazdi K., Abbattista, Antonello, Peltz, Gerson, Felip, Enriqueta
Publicado 2020

Brief Report: Declining Rates of SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies

por Meador, Catherine B., Naranbhai, Vivek, Hambelton, Grace, Rivera, Julia, Nabel, Christopher S., Lewinsohn, Rebecca, Sakhi, Mustafa, Balazs, Alejandro B., Iafrate, A. John, Gainor, Justin F.
Publicado 2023

Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2

por Voutouri, Chrysovalantis, Hardin, C. Corey, Naranbhai, Vivek, Nikmaneshi, Mohammad R., Khandekar, Melin J., Gainor, Justin F., Stylianopoulos, Triantafyllos, Munn, Lance L., Jain, Rakesh K.
Publicado 2023

Clinical and Imaging Features of Non-Small Cell Lung Cancer with G12C KRAS Mutation

por Wu, Markus Y., Zhang, Eric W., Strickland, Matthew R., Mendoza, Dexter P., Lipkin, Lev, Lennerz, Jochen K., Gainor, Justin F., Heist, Rebecca S., Digumarthy, Subba R.
Publicado 2021

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors

por Kluger, Harriet, Barrett, J Carl, Gainor, Justin F, Hamid, Omid, Hurwitz, Michael, LaVallee, Theresa, Moss, Rebecca A, Zappasodi, Roberta, Sullivan, Ryan J, Tawbi, Hussein, Sharon, Elad
Publicado 2023

Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution

por Schneider, Jaime L., Shaverdashvili, Khvaramze, Mino-Kenudson, Mari, Digumarthy, Subba R., Do, Andrew, Liu, Audrey, Gainor, Justin F., Lennerz, Jochen K., Burns, Timothy F., Lin, Jessica J.
Publicado 2023

Phase II Study of Cabozantinib in Patients With Bone Metastasis

por Choy, Edwin, Cote, Gregory M, Michaelson, M Dror, Wirth, Lori, Gainor, Justin F, Muzikansky, Alona, Sequist, Lecia V, Sullivan, Ryan J, Fidias, Panagiotis M, Shaw, Alice, Heist, Rebecca S
Publicado 2022

Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer

por Naranbhai, Vivek, St. Denis, Kerri J., Lam, Evan C., Ofoman, Onosereme, Garcia-Beltran, Wilfredo F., Mairena, Cristhian B., Bhan, Atul K., Gainor, Justin F., Balazs, Alejandro B., Iafrate, A. John
Publicado 2022

A Phase 2 Study of Lorlatinib in Patients With ROS1-Rearranged Lung Cancer With Brain-Only Progression on Crizotinib

por Schneider, Jaime L., Muzikansky, Alona, Lin, Jessica J., Krueger, Elizabeth A., Lennes, Inga T., Jacobson, Joseph O., Cheng, Michael, Heist, Rebecca S., Piotrowska, Zofia, Gainor, Justin F., Shaw, Alice T., Dagogo-Jack, Ibiay
Publicado 2022

Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy

por Bowes, Cynthia L., Naranbhai, Vivek, St. Denis, Kerri J., Lam, Evan C., Bertaux, Brittany, Keane, Florence K., Khandekar, Melin J., Balazs, Alejandro B., Iafrate, John A., Gainor, Justin F., Willers, Henning
Publicado 2022

Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC

por Cooper, Alissa J., Muzikansky, Alona, Lennerz, Jochen, Narinesingh, Farhaana, Mino-Kenudson, Mari, Hung, Yin P., Piotrowska, Zofia, Dagogo-Jack, Ibiayi, Sequist, Lecia V., Gainor, Justin F., Lin, Jessica J., Heist, Rebecca S.
Publicado 2022